OraSure Technologies Stock Price, News & Analysis (NASDAQ:OSUR)

$18.28 +0.27 (+1.50 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$18.28
Today's Range$17.82 - $18.37
52-Week Range$10.70 - $23.01
Volume751,037 shs
Average Volume726,735 shs
Market Capitalization$1.13 billion
P/E Ratio35.84
Dividend YieldN/A
Beta1.42

About OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies logoOraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorHealthcare
SymbolNASDAQ:OSUR
CUSIP68554V10
Phone+1-503-6416115

Debt

Debt-to-Equity RatioN/A
Current Ratio7.86%
Quick Ratio7.23%

Price-To-Earnings

Trailing P/E Ratio35.843137254902
Forward P/E Ratio63.03
P/E Growth5.03

Sales & Book Value

Annual Sales$167.06 million
Price / Sales6.64
Cash Flow$0.46 per share
Price / Cash39.58
Book Value$4.26 per share
Price / Book4.29

Profitability

Trailing EPS$0.51
Net Income$30.94 million
Net Margins18.52%
Return on Equity13.09%
Return on Assets11.58%

Miscellaneous

Employees325
Outstanding Shares60,650,000

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) released its quarterly earnings results on Wednesday, February, 7th. The medical instruments supplier reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.01. The medical instruments supplier earned $52 million during the quarter, compared to the consensus estimate of $50.20 million. OraSure Technologies had a net margin of 18.52% and a return on equity of 13.09%. The firm's quarterly revenue was up 46.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.13 earnings per share. View OraSure Technologies' Earnings History.

When will OraSure Technologies make its next earnings announcement?

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for OraSure Technologies.

Where is OraSure Technologies' stock going? Where will OraSure Technologies' stock price be in 2018?

3 brokers have issued 12 month price objectives for OraSure Technologies' stock. Their predictions range from $19.00 to $24.00. On average, they anticipate OraSure Technologies' share price to reach $22.00 in the next twelve months. View Analyst Ratings for OraSure Technologies.

Who are some of OraSure Technologies' key competitors?

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the folowing people:

  • Stephen S. Tang Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 56)
  • Douglas A. Michels, President, Chief Executive Officer, Director (Age 60)
  • Ronald H. Spair, Chief Financial Officer, Chief Operating Officer, Director (Age 61)
  • Anthony Zezzo II, Executive Vice President - Marketing and Sales (Age 63)
  • Mark L. Kuna, Senior Vice President - Finance, Controller, Assistant Secretary (Age 54)
  • Michael Reed Ph.D., Senior Vice President - Research and Development, Chief Scientific Officer (Age 48)
  • Jack E. Jerrett, Senior Vice President, General Counsel, Secretary (Age 58)
  • Mara Glickman Aspinall, Director (Age 54)
  • Aradhana Sarin, Director (Age 43)
  • Michael Celano, Independent Director (Age 58)

Who owns OraSure Technologies stock?

OraSure Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.74%), Renaissance Technologies LLC (6.60%), Millennium Management LLC (2.68%), Fred Alger Management Inc. (1.78%), Acadian Asset Management LLC (1.60%) and Teachers Advisors LLC (1.59%). Company insiders that own OraSure Technologies stock include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mara G Aspinall, Mark L Kuna, Michael Celano, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Institutional Ownership Trends for OraSure Technologies.

Who sold OraSure Technologies stock? Who is selling OraSure Technologies stock?

OraSure Technologies' stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Renaissance Technologies LLC, Deutsche Bank AG, Smith Asset Management Group LP, Two Sigma Advisers LP, Gilder Gagnon Howe & Co. LLC, Cornerstone Capital Management Holdings LLC. and TIAA CREF Investment Management LLC. Company insiders that have sold OraSure Technologies company stock in the last year include Anthony Zezzo II, Brian Smith, Charles W Patrick, Douglas A Michels, Jack E Jerrett, Mark L Kuna, Michael Celano, Ronald H Spair, Ronny B Lancaster and Stephen S Phd Tang. View Insider Buying and Selling for OraSure Technologies.

Who bought OraSure Technologies stock? Who is buying OraSure Technologies stock?

OraSure Technologies' stock was bought by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Millennium Management LLC, Emerald Advisers Inc. PA, Arrowstreet Capital Limited Partnership, Allianz Asset Management GmbH, Kennedy Capital Management Inc., RTW Investments LP and First Washington CORP. View Insider Buying and Selling for OraSure Technologies.

How do I buy OraSure Technologies stock?

Shares of OraSure Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OraSure Technologies' stock price today?

One share of OraSure Technologies stock can currently be purchased for approximately $18.28.

How big of a company is OraSure Technologies?

OraSure Technologies has a market capitalization of $1.13 billion and generates $167.06 million in revenue each year. The medical instruments supplier earns $30.94 million in net income (profit) each year or $0.51 on an earnings per share basis. OraSure Technologies employs 325 workers across the globe.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 150 WEBSTER ST, BETHLEHEM, PA 18015, United States. The medical instruments supplier can be reached via phone at +1-503-6416115 or via email at [email protected]


MarketBeat Community Rating for OraSure Technologies (OSUR)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  316 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about OraSure Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OraSure Technologies (NASDAQ:OSUR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.752.802.83
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.00$18.81$17.25$15.04
Price Target Upside: 2.09% upside4.75% downside12.66% downside25.35% downside

OraSure Technologies (NASDAQ:OSUR) Consensus Price Target History

Price Target History for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ:OSUR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/2/2018Canaccord GenuityReiterated RatingBuy$24.00LowView Rating Details
11/2/2017Jefferies GroupDowngradeBuy -> HoldN/AView Rating Details
7/11/2017StephensReiterated RatingOverweight$14.00 -> $19.00LowView Rating Details
2/9/2017Raymond James FinancialUpgradeMarket Perform -> Outperform$11.25N/AView Rating Details
12/20/2016CL KingInitiated CoverageBuy$11.00N/AView Rating Details
9/19/2016BTIG ResearchDowngradeBuy -> Neutral$8.00N/AView Rating Details
7/5/2016MizuhoReiterated RatingOutperform$8.00N/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

OraSure Technologies (NASDAQ:OSUR) Earnings History and Estimates Chart

Earnings by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ OSUR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$0.08N/AView Earnings Details
2/7/2018Q4 2017$0.11$0.12$50.20 million$52.00 millionViewListenView Earnings Details
11/1/2017Q3 2017$0.09$0.09$40.87 million$42.30 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.07$0.09$36.54 million$40.18 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.17$0.21$31.19 million$32.55 millionViewListenView Earnings Details
2/8/2017Q4 2016$0.06$0.13$34.80 million$35.50 millionViewListenView Earnings Details
11/2/2016Q316$0.07$0.11$31.45 million$32.25 millionViewListenView Earnings Details
8/3/2016Q216$0.05$0.07$31.15 million$31.36 millionViewListenView Earnings Details
5/4/2016Q1$0.02$0.04$28.82 million$29.10 millionViewListenView Earnings Details
2/3/2016Q4$0.03$0.08$29.73 million$32.38 millionViewListenView Earnings Details
11/4/2015Q315($0.01)$0.03$29.58 million$29.90 millionViewListenView Earnings Details
8/5/2015Q215$0.01$0.03$28.95 million$30.34 millionViewListenView Earnings Details
2/4/2015Q414($0.04)($0.05)$28.22 million$28.68 millionViewListenView Earnings Details
11/5/2014Q314($0.05)$0.02$27.20 million$27.85 millionViewListenView Earnings Details
8/6/2014Q214($0.04)$0.04$26.21 million$26.40 millionViewListenView Earnings Details
5/7/2014Q114($0.13)($0.10)$23.28 million$23.50 millionViewListenView Earnings Details
2/5/2014Q413($0.08)$0.11$27.43 million$28.80 millionViewListenView Earnings Details
11/6/2013Q313($0.10)($0.03)$24.21 million$24.70 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.16)($0.10)$23.67 million$24.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.18)($0.18)$20.82 million$21.20 millionViewListenView Earnings Details
2/6/2013Q4 2012($0.14)($0.11)$20.87 million$22.14 millionViewListenView Earnings Details
11/7/2012Q312($0.07)($0.04)$22.26 million$22.10 millionViewN/AView Earnings Details
8/7/2012($0.08)($0.07)ViewN/AView Earnings Details
5/2/2012($0.09)($0.07)ViewN/AView Earnings Details
2/8/2012Q4 2011($0.07)$0.02ViewN/AView Earnings Details
11/2/2011($0.07)($0.03)ViewN/AView Earnings Details
8/3/2011($0.05)($0.05)ViewN/AView Earnings Details
5/5/2011($0.08)($0.06)ViewN/AView Earnings Details
2/9/2011($0.08)($0.02)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.04)$0.01ViewN/AView Earnings Details
8/4/2010Q2 2010($0.08)($0.01)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.06)($0.05)ViewN/AView Earnings Details
2/10/2010Q4 2009($0.08)($0.03)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.05)$0.04ViewN/AView Earnings Details
8/5/2009Q2 2009($0.07)($0.05)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.07)($0.04)ViewN/AView Earnings Details
2/11/2009Q4 2008($0.10)($0.07)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.11)($0.04)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.08)($0.05)ViewN/AView Earnings Details
5/6/2008Q1 2008$0.03$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

OraSure Technologies (NASDAQ:OSUR) Earnings Estimates

2018 EPS Consensus Estimate: $0.28
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.06)($0.06)($0.06)
Q2 20181$0.04$0.04$0.04
Q3 20181$0.10$0.10$0.10
Q4 20181$0.20$0.20$0.20
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for OraSure Technologies (NASDAQ:OSUR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

OraSure Technologies (NASDAQ OSUR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.40%
Institutional Ownership Percentage: 91.62%
Insider Trades by Quarter for OraSure Technologies (NASDAQ:OSUR)
Insider Trades by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ OSUR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2017Mara G AspinallDirectorBuy5,000$14.23$71,150.005,000View SEC Filing  
10/4/2017Douglas A MichelsCEOSell22,923$23.00$527,229.00View SEC Filing  
9/29/2017Douglas A MichelsCEOSell25,000$22.55$563,750.00743,058View SEC Filing  
8/31/2017Brian SmithInsiderSell9,112$20.47$186,522.6432,477View SEC Filing  
8/30/2017Charles W PatrickDirectorSell1,000$20.11$20,110.0051,104View SEC Filing  
8/22/2017Brian SmithInsiderSell3,075$21.09$64,851.7524,540View SEC Filing  
8/7/2017Anthony Zezzo IIEVPSell72,916$21.26$1,550,194.16218,326View SEC Filing  
8/7/2017Jack E JerrettSVPSell73,463$20.77$1,525,826.5181,593View SEC Filing  
8/7/2017Ronald H SpairCFOSell510,112$20.66$10,538,913.92208,606View SEC Filing  
6/27/2017Douglas A MichelsCEOSell290,495$16.75$4,865,791.25894,012View SEC Filing  
5/30/2017Ronny B LancasterDirectorSell89,684$14.79$1,326,426.366,295View SEC Filing  
5/10/2017Anthony Zezzo IIEVPSell115,000$14.70$1,690,500.00260,410View SEC Filing  
5/9/2017Douglas A MichelsCEOSell209,800$15.01$3,149,098.00782,025View SEC Filing  
5/8/2017Douglas A MichelsCEOSell361,216$15.08$5,447,137.28881,620View SEC Filing  
5/8/2017Mark L KunaSVPSell36,413$15.11$550,200.4392,904View SEC Filing  
5/8/2017Ronald H SpairCFOSell72,564$15.00$1,088,460.00175,130View SEC Filing  
5/5/2017Michael CelanoDirectorSell44,962$14.95$672,181.9038,117View SEC Filing  
3/21/2017Stephen S Phd TangDirectorSell220$12.00$2,640.0031,748View SEC Filing  
2/28/2017Charles W PatrickDirectorSell29,883$11.29$337,379.0774,959View SEC Filing  
2/16/2017Ronald H SpairCFOSell50,000$11.12$556,000.00View SEC Filing  
2/15/2017Jack E JerrettSVPSell107,288$11.06$1,186,605.2880,842View SEC Filing  
2/15/2017Stephen S Phd TangDirectorSell40,000$11.04$441,600.0078,068View SEC Filing  
2/14/2017Ronald H SpairCFOSell63,720$10.60$675,432.00169,860View SEC Filing  
2/10/2017Mark L KunaSVPSell79,271$10.61$841,065.3163,491View SEC Filing  
1/31/2017Michael CelanoDirectorSell15,000$8.78$131,700.00108,079View SEC Filing  
1/17/2017Ronald H SpairCFOSell3,341$8.71$29,100.11106,663View SEC Filing  
12/15/2016Mark L KunaSVPSell10,000$9.30$93,000.0082,965View SEC Filing  
12/13/2016Douglas A MichelsCEOSell71,466$9.07$648,196.62747,114View SEC Filing  
12/13/2016Mark L KunaSVPSell17,000$9.11$154,870.0084,965View SEC Filing  
12/9/2016Mark L KunaSVPSell3,000$9.03$27,090.0075,965View SEC Filing  
11/23/2016Douglas A MichelsCEOSell30,893$9.02$278,654.86731,898View SEC Filing  
11/23/2016Jack E JerrettSVPSell24,000$9.00$216,000.0060,105View SEC Filing  
9/26/2016Douglas A MichelsCEOSell25,000$8.22$205,500.00756,898View SEC Filing  
8/31/2016Charles W PatrickDirectorSell17,483$8.58$150,004.1477,209View SEC Filing  
8/30/2016Jack E JerrettSVPSell68,686$8.52$585,204.7286,441View SEC Filing  
8/29/2016Charles W PatrickDirectorSell2,250$8.94$20,115.0077,209View SEC Filing  
8/5/2016Charles W PatrickDirectorSell6,575$7.24$47,603.0077,209View SEC Filing  
12/19/2014Ronald H SpairCFOSell75,974$10.01$760,499.74View SEC Filing  
12/9/2014Ronald H SpairCFOSell1,026$10.00$10,260.00View SEC Filing  
12/8/2014Ronald H SpairCFOSell126$10.00$1,260.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OraSure Technologies (NASDAQ OSUR) News Headlines

Source:
DateHeadline
$40.55 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter$40.55 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter
www.americanbankingnews.com - February 17 at 2:44 AM
Zacks: Brokerages Expect OraSure Technologies, Inc. (OSUR) Will Announce Earnings of -$0.06 Per ShareZacks: Brokerages Expect OraSure Technologies, Inc. (OSUR) Will Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - February 15 at 5:06 PM
Jefferies Group Comments on OraSure Technologies, Inc.s Q1 2018 Earnings (OSUR)Jefferies Group Comments on OraSure Technologies, Inc.'s Q1 2018 Earnings (OSUR)
www.americanbankingnews.com - February 15 at 8:30 AM
OraSure Technologies, Inc. (OSUR) Expected to Earn Q2 2018 Earnings of $0.04 Per ShareOraSure Technologies, Inc. (OSUR) Expected to Earn Q2 2018 Earnings of $0.04 Per Share
www.americanbankingnews.com - February 14 at 8:20 AM
OraSure Technologies (OSUR) Downgraded by Zacks Investment ResearchOraSure Technologies (OSUR) Downgraded by Zacks Investment Research
www.americanbankingnews.com - February 13 at 6:30 AM
Stock Traders Buy High Volume of Call Options on OraSure Technologies (OSUR)Stock Traders Buy High Volume of Call Options on OraSure Technologies (OSUR)
www.americanbankingnews.com - February 11 at 1:32 AM
OraSure Technologies (OSUR) Stock Rating Upgraded by Zacks Investment ResearchOraSure Technologies (OSUR) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - February 9 at 6:30 AM
OraSure Technologies (OSUR) Releases  Earnings Results, Beats Estimates By $0.01 EPSOraSure Technologies (OSUR) Releases Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - February 8 at 1:22 PM
OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial ResultsOraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
finance.yahoo.com - February 8 at 8:50 AM
OraSure Technologies (OSUR) Stock Rating Reaffirmed by Canaccord GenuityOraSure Technologies (OSUR) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - February 2 at 8:18 PM
OraSure Technologies, Inc. (OSUR) Given Average Rating of "Buy" by BrokeragesOraSure Technologies, Inc. (OSUR) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 2 at 5:42 PM
OraSure Technologies (OSUR) Names Aradhana Sarin M.D. to BoardOraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board
www.streetinsider.com - February 2 at 4:30 PM
OraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board - StreetInsider.comOraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board - StreetInsider.com
www.streetinsider.com - February 2 at 9:14 AM
OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of DirectorsOraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
finance.yahoo.com - February 2 at 9:14 AM
Whats Happening With These Medical Supplies Stocks? -- Tandem Diabetes Care, Integra LifeSciences, OraSure Technologies, and InsuletWhat's Happening With These Medical Supplies Stocks? -- Tandem Diabetes Care, Integra LifeSciences, OraSure Technologies, and Insulet
www.bizjournals.com - February 1 at 9:19 AM
OraSure Technologies (OSUR) Set to Announce Quarterly Earnings on ThursdayOraSure Technologies (OSUR) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - February 1 at 1:38 AM
OraSure Technologies Sees Unusually High Options Volume (OSUR)OraSure Technologies Sees Unusually High Options Volume (OSUR)
www.americanbankingnews.com - January 28 at 1:06 AM
OraSure Technologies (OSUR) Upgraded by BidaskClub to "Strong-Buy"OraSure Technologies (OSUR) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - January 20 at 9:10 AM
Stocks To Watch: Orasure Technologies Sees RS Rating Jump To 93Stocks To Watch: Orasure Technologies Sees RS Rating Jump To 93
finance.yahoo.com - January 17 at 4:45 PM
$47.97 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter$47.97 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter
www.americanbankingnews.com - January 14 at 4:30 AM
OraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment ResearchOraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - January 9 at 9:02 AM
OraSure Technologies, Inc. (OSUR) Receives Average Rating of "Buy" from AnalystsOraSure Technologies, Inc. (OSUR) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - January 8 at 3:38 PM
Why OraSure Technologies, Inc. Rallied 10.8% in DecemberWhy OraSure Technologies, Inc. Rallied 10.8% in December
finance.yahoo.com - January 6 at 10:11 AM
OraSure Technologies to Present at the 36th Annual JP Morgan Healthcare Conference - NasdaqOraSure Technologies to Present at the 36th Annual JP Morgan Healthcare Conference - Nasdaq
www.nasdaq.com - January 5 at 10:24 AM
OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare ConferenceOraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference
feeds.benzinga.com - January 5 at 7:25 AM
OraSure Technologies (OSUR) Boosts 4Q Revenue Guidance; Announces CEO & CFO Succession Plans - StreetInsider.comOraSure Technologies (OSUR) Boosts 4Q Revenue Guidance; Announces CEO & CFO Succession Plans - StreetInsider.com
www.streetinsider.com - January 4 at 10:09 AM
OraSure Technologies Announces Management Succession PlanOraSure Technologies Announces Management Succession Plan
finance.yahoo.com - January 4 at 10:09 AM
University City Science Center CEO stepping downUniversity City Science Center CEO stepping down
finance.yahoo.com - January 4 at 10:09 AM
Recro Pharma Announces Key Executive Promotions to the Financial TeamRecro Pharma Announces Key Executive Promotions to the Financial Team
finance.yahoo.com - January 3 at 9:31 AM
OraSure Technologies (OSUR) Upgraded at Zacks Investment ResearchOraSure Technologies (OSUR) Upgraded at Zacks Investment Research
www.americanbankingnews.com - December 30 at 6:14 AM
OraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $45.27 MillionOraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $45.27 Million
www.americanbankingnews.com - December 29 at 8:54 PM
ETFs with exposure to OraSure Technologies, Inc. : December 27, 2017ETFs with exposure to OraSure Technologies, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 2:36 PM
$0.09 EPS Expected for OraSure Technologies, Inc. (OSUR) This Quarter$0.09 EPS Expected for OraSure Technologies, Inc. (OSUR) This Quarter
www.americanbankingnews.com - December 27 at 7:28 AM
OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 10:10 AM
Steris (STE) vs. OraSure Technologies (OSUR) Financial ContrastSteris (STE) vs. OraSure Technologies (OSUR) Financial Contrast
www.americanbankingnews.com - December 24 at 1:31 AM
OraSure Technologies (OSUR) Lifted to Buy at BidaskClubOraSure Technologies (OSUR) Lifted to Buy at BidaskClub
www.americanbankingnews.com - December 21 at 10:02 PM
Head to Head Review: OraSure Technologies (OSUR) versus Sientra (SIEN)Head to Head Review: OraSure Technologies (OSUR) versus Sientra (SIEN)
www.americanbankingnews.com - December 14 at 11:04 PM
OraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by AnalystsOraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 14 at 8:28 PM
Quotidian Technical Highlights on Selected Medical Supplies Stocks ... - PR Newswire (press release)Quotidian Technical Highlights on Selected Medical Supplies Stocks ... - PR Newswire (press release)
www.prnewswire.com - December 12 at 4:59 PM
Quotidian Technical Highlights on Selected Medical Supplies Stocks -- OraSure Technologies, Hill-Rom, Tandem Diabetes Care, and Mazor RoboticsQuotidian Technical Highlights on Selected Medical Supplies Stocks -- OraSure Technologies, Hill-Rom, Tandem Diabetes Care, and Mazor Robotics
www.bizjournals.com - December 12 at 10:41 AM
Zacks: Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $45.27 MillionZacks: Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $45.27 Million
www.americanbankingnews.com - December 11 at 4:32 AM
OraSure Technologies Announces 2018 Annual Meeting Date - GlobeNewswire (press release)OraSure Technologies Announces 2018 Annual Meeting Date - GlobeNewswire (press release)
globenewswire.com - December 8 at 10:13 AM
OraSure Technologies (OSUR) Lifted to "Hold" at Zacks Investment ResearchOraSure Technologies (OSUR) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - December 2 at 7:24 AM
AtriCure (ATRC) versus OraSure Technologies (OSUR) Head-To-Head SurveyAtriCure (ATRC) versus OraSure Technologies (OSUR) Head-To-Head Survey
www.americanbankingnews.com - December 1 at 11:38 AM
OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV TestingOraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
finance.yahoo.com - November 30 at 4:39 PM
OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell in Honor of World AIDS Day - GlobeNewswire (press release)OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell in Honor of World AIDS Day - GlobeNewswire (press release)
globenewswire.com - November 30 at 10:52 AM
OraSure Technologies, Inc. (OSUR) Short Interest Down 71.2% in NovemberOraSure Technologies, Inc. (OSUR) Short Interest Down 71.2% in November
www.americanbankingnews.com - November 28 at 2:38 AM
OraSure Technologies Target of Unusually Large Options Trading (OSUR)OraSure Technologies Target of Unusually Large Options Trading (OSUR)
www.americanbankingnews.com - November 25 at 1:02 AM
OraSure Technologies IncOraSure Technologies Inc
www.bloomberg.com - November 23 at 7:16 AM
OraSure Technologies (OSUR) Subsidiary Enters $143M Supply Deal for Oragene DxOraSure Technologies (OSUR) Subsidiary Enters $143M Supply Deal for Oragene Dx
www.streetinsider.com - November 23 at 7:16 AM

SEC Filings

OraSure Technologies (NASDAQ:OSUR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

OraSure Technologies (NASDAQ:OSUR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

OraSure Technologies (NASDAQ OSUR) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.